The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...

Merck's drug is an antiretroviral treatment, a combination of medicines used to stop the reproduction of the virus.

The Food and Drug Administration has approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections. The drug will be ...

Millions of people, particularly in African countries, have lost access to drug treatments, prevention and testing putting ...

Zimbabwe was selected as one of the 10 countries globally to roll out Lenacapavir, which is described as one of the most ...

The World Health Organization (WHO) yesterday released a roadmap to address rising resistance to treatments for HIV, ...

Miguel, a 63-year-old Los Angeles teacher, recently marked the 38th anniversary of his diagnosis with HIV. The doctor had told him he would be dead in a couple of years. He lived fearful that each ...

A slum-based healthcare rights organisation wants the new HIV prevention drug to be first rolled out in poor neighbourhoods to bear much of the epidemic’s brunt. The lobby also wants healthcare ...

Medicaid expansion under the Affordable Care Act (ACA) significantly increased the number of people at risk of HIV diagnosis ...

In April 2025, we published a story with the headline: "Haunted by hopelessness: 12 Zambians share their stories as HIV drugs run out." It looked at the impact of President Trump's cuts to foreign aid ...

A new pre-exposure prophylaxis (PrEP) drug has shown promise as a once-monthly oral pill to help prevent HIV. PrEP plays a key part in reducing the number of new HIV infections by stopping the virus ...

In this Oct. 7, 2019, file photo, a pharmacist displays the HIV prevention drugs Descovy, left and Truvada, right, at a pharmacy in Sacramento, Calif. A proposed federal policy aims to protect older ...